Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
European Journal of Biochemistry
|
September 17, 2002
Role of Ca2+/calmodulin regulated signaling pathways in chemoattractant induced neutrophil effector functions. Comparison with the role of phosphotidylinositol-3 kinase
Sandra Verploegen, Caroline M van Leeuwen, Hanneke W M van Deutekom, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 8, 2012
Crosstalk between human IgG isotypes and murine effector cells
Marije B Overdijk, Sandra Verploegen, Antonio Ortiz Buijsse, et al.
Blood
|
September 25, 2007
Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis
Miranda Buitenhuis, Liesbeth P Verhagen, Hanneke W M van Deutekom, et al.
Blood
|
April 21, 2005
Characterization of the role of CaMKI-like kinase (CKLiK) in human granulocyte function
Sandra Verploegen, Laurien Ulfman, Hanneke W M van Deutekom, et al.
Molecular Cancer Therapeutics
|
November 2, 2018
CD3-Bispecific Antibody Therapy Turns Solid Tumors into Inflammatory Sites but Does Not Install Protective Memory
Hreinn Benonisson, Işıl Altıntaş, Marjolein Sluijter, et al.
Scientific Reports
|
June 1, 2017
Efficient Generation of Bispecific Murine Antibodies for Pre-Clinical Investigations in Syngeneic Rodent Models
Aran F Labrijn, Joyce I Meesters, Matthew Bunce, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 12, 2011
Epidermal growth factor receptor (EGFR) antibody-induced antibody-dependent cellular cytotoxicity plays a prominent role in inhibiting tumorigenesis, even of tumor cells insensitive to EGFR signaling inhibition
Marije B Overdijk, Sandra Verploegen, Jeroen H van den Brakel, et al.
Journal of Oncology
|
January 17, 2022
Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer Cells
Mandy Gruijs, Rens Braster, Marije B Overdijk, et al.
Cancer Research
|
December 28, 2013
An antibody-drug conjugate that targets tissue factor exhibits potent therapeutic activity against a broad range of solid tumors
Esther C W Breij, Bart E C G de Goeij, Sandra Verploegen, et al.
Mabs
|
March 12, 2015
Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma
Marije B Overdijk, Sandra Verploegen, Marijn Bögels, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
European Journal of Biochemistry
|
September 17, 2002
Role of Ca2+/calmodulin regulated signaling pathways in chemoattractant induced neutrophil effector functions. Comparison with the role of phosphotidylinositol-3 kinase
Sandra Verploegen, Caroline M van Leeuwen, Hanneke W M van Deutekom, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 8, 2012
Crosstalk between human IgG isotypes and murine effector cells
Marije B Overdijk, Sandra Verploegen, Antonio Ortiz Buijsse, et al.
Blood
|
September 25, 2007
Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis
Miranda Buitenhuis, Liesbeth P Verhagen, Hanneke W M van Deutekom, et al.
Blood
|
April 21, 2005
Characterization of the role of CaMKI-like kinase (CKLiK) in human granulocyte function
Sandra Verploegen, Laurien Ulfman, Hanneke W M van Deutekom, et al.
Molecular Cancer Therapeutics
|
November 2, 2018
CD3-Bispecific Antibody Therapy Turns Solid Tumors into Inflammatory Sites but Does Not Install Protective Memory
Hreinn Benonisson, Işıl Altıntaş, Marjolein Sluijter, et al.
Scientific Reports
|
June 1, 2017
Efficient Generation of Bispecific Murine Antibodies for Pre-Clinical Investigations in Syngeneic Rodent Models
Aran F Labrijn, Joyce I Meesters, Matthew Bunce, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 12, 2011
Epidermal growth factor receptor (EGFR) antibody-induced antibody-dependent cellular cytotoxicity plays a prominent role in inhibiting tumorigenesis, even of tumor cells insensitive to EGFR signaling inhibition
Marije B Overdijk, Sandra Verploegen, Jeroen H van den Brakel, et al.
Journal of Oncology
|
January 17, 2022
Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer Cells
Mandy Gruijs, Rens Braster, Marije B Overdijk, et al.
Cancer Research
|
December 28, 2013
An antibody-drug conjugate that targets tissue factor exhibits potent therapeutic activity against a broad range of solid tumors
Esther C W Breij, Bart E C G de Goeij, Sandra Verploegen, et al.
Mabs
|
March 12, 2015
Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma
Marije B Overdijk, Sandra Verploegen, Marijn Bögels, et al.
Page
of 2